Land Therapeutics Inc.
Cambridge, Massachusetts, United StatesPurpose
to develop an affordable in vivo gene therapy for sickle cell disease
Grantee
Division
Global Health
Date
OCTOBER 2025
Region served
GLOBAL
Committed amount
$4,997,221
Grant topic
Create Novel Technology Platform Capabilities
Duration (months)
22
Grantee location
Cambridge, Massachusetts, United States
More about our financials
Our work
Learn about where we work around the globe and the programs we’ve created to address urgent issues in global health, global development, and education.
How we work
We are focused on results. Those that can be measured. And those measured in ways beyond numbers.